Method | Drug | FLX: OLZ. (µg mL− 1) | Found ( µg mL− 1) | % Recovery a ± SD | RSD |
---|---|---|---|---|---|
Ratio Subtract | OLZ | 8:4 | 4.01 | 100.31 ± 0.375 | 0.374 |
 | 12:6 | 6.08 | 101.46 ± 0.30 | 0.296 | |
 | 16:8 | 7.99 | 99.94 ± 0.451 | 0.45 | |
 | 20:10 | 9.88 | 98.85 ± 0.543 | 0.549 | |
 | FLX | 8:4 | 8.07 | 100.85 ± 0.64 | 0.63 |
 | 12:6 | 12.07 | 100.59 ± 0.283 | 0.281 | |
 | 16:8 | 15.84 | 98.97 ± 0.283 | 0.285 | |
 | 20:10 | 19.97 | 99.83 ± 0.296 | 0.297 | |
Dual wavelengths | FLX | 12:6 | 12 | 100.01 ± 0.908 | 0.907 |
 | 16:8 | 16.07 | 100.46 ± 0.851 | 0.847 | |
 | 20:10 | 19.99 | 99.98 ± 1.021 | 1.021 | |
 | 24:12 | 23.94 | 99.78 ± 0.851 | 0.853 | |
Absorptivity factor | OLZ | 12:6 | 5.94 | 99.11 ± 1.26 | 1.27 |
 | 16:8 | 7.97 | 99.68 ± 1.15 | 1.16 | |
 | 20:10 | 9.92 | 99.2 ± 0.335 | 0.338 | |
 | 24:12 | 11.93 | 99.46 ± 1.191 | 1.197 |